Literature DB >> 35503009

Btg2 mutation induces renal injury and impairs blood pressure control in female rats.

Matthew J Hoffman1,2, Akiko Takizawa1, Eric S Jensen3,4, Rebecca Schilling1,2, Michael Grzybowski1,2, Aron M Geurts1,2, Melinda R Dwinell1,2.   

Abstract

Hypertension (HTN) is a complex disease influenced by heritable genetic elements and environmental interactions. Dietary salt is among the most influential modifiable factors contributing to increased blood pressure (BP). It is well established that men and women develop BP impairment in different patterns and a recent emphasis has been placed on identifying mechanisms leading to the differences observed between the sexes in HTN development. The current work reported here builds on an extensive genetic mapping experiment that sought to identify genetic determinants of salt-sensitive (SS) HTN using the Dahl SS rat. BTG antiproliferation factor 2 (Btg2) was previously identified by our group as a candidate gene contributing to SS HTN in female rats. In the current study, Btg2 was mutated using transcription activator-like effector nuclease (TALEN)-targeted gene disruption on the SSBN congenic rat background. The Btg2 mutated rats exhibited impaired BP and proteinuria responses to a high-salt diet compared with wild-type rats. Differences in body weight, mutant pup viability, skeletal morphology, and adult nephron density suggest a potential role for Btg2 in developmental signaling pathways. Subsequent cell cycle gene expression assessment provides several additional signaling pathways that Btg2 may function through during salt handling in the kidney. The expression analysis also identified several potential upstream targets that can be explored to further isolate therapeutic approaches for SS HTN.

Entities:  

Keywords:  TALEN; hypertension; renal; salt sensitivity

Mesh:

Substances:

Year:  2022        PMID: 35503009      PMCID: PMC9208437          DOI: 10.1152/physiolgenomics.00167.2021

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   4.297


  65 in total

Review 1.  Chromosomal Substitution Strategies to Localize Genomic Regions Related to Complex Traits.

Authors:  Allen W Cowley; Melinda R Dwinell
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 9.090

2.  Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.

Authors:  Bodo B Beck; Howard Trachtman; Michael Gitman; Ilene Miller; John A Sayer; Andrea Pannes; Anne Baasner; Friedhelm Hildebrandt; Matthias T F Wolf
Journal:  Am J Kidney Dis       Date:  2011-09-08       Impact factor: 8.860

Review 3.  The use of designer rats in the genetic dissection of hypertension.

Authors:  A E Kwitek-Black; H J Jacob
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

4.  Investigating the effect of genetic background on proteinuria and renal injury using two hypertensive strains.

Authors:  Matthew Packard; Yasser Saad; William T Gunning; Shalini Gupta; Joseph Shapiro; Michael R Garrett
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-28

5.  Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.

Authors:  Hirofumi Kawakubo; Jennifer L Carey; Elena Brachtel; Vandana Gupta; Jeffrey E Green; Paul D Walden; Shyamala Maheswaran
Journal:  Oncogene       Date:  2004-10-28       Impact factor: 9.867

6.  Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor.

Authors:  Sudipan Karmakar; Estrella A Foster; Carolyn L Smith
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

7.  Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats.

Authors:  Carol Moreno; Pierre Dumas; Mary L Kaldunski; Peter J Tonellato; Andrew S Greene; Richard J Roman; Qunli Cheng; Zhitao Wang; Howard J Jacob; Allen W Cowley
Journal:  Physiol Genomics       Date:  2003-11-11       Impact factor: 3.107

8.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

9.  The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.

Authors:  William J Astle; Heather Elding; Tao Jiang; Dave Allen; Dace Ruklisa; Alice L Mann; Daniel Mead; Heleen Bouman; Fernando Riveros-Mckay; Myrto A Kostadima; John J Lambourne; Suthesh Sivapalaratnam; Kate Downes; Kousik Kundu; Lorenzo Bomba; Kim Berentsen; John R Bradley; Louise C Daugherty; Olivier Delaneau; Kathleen Freson; Stephen F Garner; Luigi Grassi; Jose Guerrero; Matthias Haimel; Eva M Janssen-Megens; Anita Kaan; Mihir Kamat; Bowon Kim; Amit Mandoli; Jonathan Marchini; Joost H A Martens; Stuart Meacham; Karyn Megy; Jared O'Connell; Romina Petersen; Nilofar Sharifi; Simon M Sheard; James R Staley; Salih Tuna; Martijn van der Ent; Klaudia Walter; Shuang-Yin Wang; Eleanor Wheeler; Steven P Wilder; Valentina Iotchkova; Carmel Moore; Jennifer Sambrook; Hendrik G Stunnenberg; Emanuele Di Angelantonio; Stephen Kaptoge; Taco W Kuijpers; Enrique Carrillo-de-Santa-Pau; David Juan; Daniel Rico; Alfonso Valencia; Lu Chen; Bing Ge; Louella Vasquez; Tony Kwan; Diego Garrido-Martín; Stephen Watt; Ying Yang; Roderic Guigo; Stephan Beck; Dirk S Paul; Tomi Pastinen; David Bujold; Guillaume Bourque; Mattia Frontini; John Danesh; David J Roberts; Willem H Ouwehand; Adam S Butterworth; Nicole Soranzo
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

10.  Btg2 is a Negative Regulator of Cardiomyocyte Hypertrophy through a Decrease in Cytosolic RNA.

Authors:  Yuki Masumura; Shuichiro Higo; Yoshihiro Asano; Hisakazu Kato; Yi Yan; Saki Ishino; Osamu Tsukamoto; Hidetaka Kioka; Takaharu Hayashi; Yasunori Shintani; Satoru Yamazaki; Tetsuo Minamino; Masafumi Kitakaze; Issei Komuro; Seiji Takashima; Yasushi Sakata
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.